S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TERN Terns Pharmaceuticals Inc

3.55

0.19 (5.65%)

12 Mar 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals Inc News

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)
Thursday 27 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
Tuesday 25 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 21 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors
Friday 21 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Thursday 6 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

More Terns Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions